1. Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase
- Author
-
Ann Greer, Stoffan Karen M, Joan M. Carboni, Bruce L. Jacobson, Zoeckler Mary Edson, Marco M. Gottardis, Dolatrai M. Vyas, Ricardo M. Attar, Aixin Li, Steven Hansel, Subramaniam Krishnanathan, Mark D. Wittman, Pieying Liu, Chiehying Chang, Yax Sun, Upender Velaparthi, and Balu Balasubramanian
- Subjects
Models, Molecular ,Pyridones ,medicine.medical_treatment ,Clinical Biochemistry ,Pharmaceutical Science ,Biochemistry ,Cell Line ,Mice ,Structure-Activity Relationship ,Insulin-like growth factor ,Growth factor receptor ,Drug Discovery ,medicine ,Animals ,Structure–activity relationship ,Insulin-Like Growth Factor I ,Molecular Biology ,Cell Proliferation ,chemistry.chemical_classification ,biology ,Kinase ,Growth factor ,Phosphotransferases ,Organic Chemistry ,Enzyme ,chemistry ,Enzyme inhibitor ,biology.protein ,Molecular Medicine ,Benzimidazoles ,Indicators and Reagents ,Signal transduction ,Baculoviridae ,Thymidine - Abstract
A novel class of 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase is described. This report discusses the SAR of 4-(2-hydroxy-2-phenylethylamino)-substituted pyridones with improved IGF-1R potency.
- Published
- 2007
- Full Text
- View/download PDF